发明名称 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
摘要 The invention provides the use of a cyclodextrin compound for the manufacturing of a medicament for the treatment or prevention of bronchial inflammatory diseases, particularly for asthma and chronic obstructive pulmonary disease (COPD).
申请公布号 US9034846(B2) 申请公布日期 2015.05.19
申请号 US201313804626 申请日期 2013.03.14
申请人 UNIVERSITE DE LIEGE 发明人 Cataldo Didier;Evrard Brigitte;Noel Agnes;Foldart Jean-Michel
分类号 A61K31/724;A61P11/00;A61K9/00 主分类号 A61K31/724
代理机构 Jacobson Holman, PLLC. 代理人 Jacobson Holman, PLLC.
主权项 1. A method for the treatment of COPD (Chronic obstruction pulmonary disease) in a host mammal in need of such treatment, comprising the step of administering a composition consisting essentially of an effective amount of cyclodextrin compound to the mammal, wherein the cyclodextrin compound is selected from the group consisting of b-cyclodextrin, hydroxypropyl-bcyclodextrin, sulfolbutylether-bcyclodextrin, random methylated-bcyclodextrin, dimethyl-bcyclodextrin, trimethyl-bcyclodextrin, hydroxypropyl b-cyclodextrin, hydroxybutyl bcyclodextrin, glucosyl-bcyclodextrin, maltosyl-bcyclodextrin, 2-O-methyl-bcyclodextrin or a combination thereof and their pharmaceutically acceptable salts.
地址 Angleur BE